<DOC>
	<DOCNO>NCT00775177</DOCNO>
	<brief_summary>The purpose study determine bioequivalence Doxycycline monohydrate formulation administration single dos normal healthy subject fast condition . These data evaluate statistically determine product meet bioequivalence criterion .</brief_summary>
	<brief_title>Bioequivalence Study Doxycycline Monohydrate 100mg Tablets Under Fasting Conditions</brief_title>
	<detailed_description>The study conduct open label , balance , randomise , two-treatment , two-period , two-sequence , single-dose , crossover , bioequivalence study Doxycycline monohydrate compare Doxycycline monohydrate 100mg tablet Ranbaxy Pharmaceuticals Inc Adoxa ® 100mg tablet Bradley Pharmaceuticals , Inc. healthy , adult , human , subject fast condition . A total 32 non-smoking subject ( men woman ) include study , 31 finish study accord protocol ,</detailed_description>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>) Healthy male female subject least 18 year age . b ) Informed nature study give write informed consent . c ) Have body mass index 18 30 weigh least 110 pound . ) In good health determine lack clinically significant abnormality health assessment perform screen judged physician . ) Hypersensitivity Doxycycline monohydrate ( Adoxa® ) , related compound tetracycline . b ) Any history clinical condition might affect drug absorption , metabolism passage body , e.g . sprue , celiac disease , Crohn 's disease , colitis , liver , kidney thyroid condition . c ) Recent history mental illness , drug addiction , drug abuse alcoholism . ) Donation great 500 ml blood past 4 week prior study dose difficulty donate blood . e ) Received investigational drug within 4 week prior study dose . f ) Currently take systemic prescription medication , except oral/ cutaneous/ vaginal hormone contraceptive , within 7 day prior study dose overthecounter medication within 3 day study dose . This prohibition include vitamin herbal preparation take nutritional supplement nontherapeutic indication judge attend physician . Any nonprescription medication consumption report reviewed investigator prior dose . At discretion investigator volunteer may enrol medication anticipate alter study integrity . g ) Regular smoke 5 cigarette per week daily use nicotinecontaining product begin 3 month study medication administration final evaluation . h ) If female , subject lactate positive pregnancy test screen prior two treatment period . Females child bear potential must use 'medically acceptable method contraception throughout entire study period one week study complete . Medically acceptable method contraception may use subject and/or partner : oral contraceptives/ patch , progestin injection/ implant , condom spermacide , diaphragm spermacide , IUD , vaginal spermicidal suppository , surgical Sterilization partner ( ) abstinence . Females take oral Contraceptives must take consistently least three month prior receive study medication . ) Alcohol , grapefruit beverage foods caffeine beverage foods begin 24 hour study medication administration study confinement period . Such restricted item include coffee , tea , iced tea , coke , Pepsi , Mountain Dew , chocolate , brownie , etc . j ) Significant history current evidence chronic infectious disease , system disorder organ dysfunction k ) Regular use drug know induce inhibit hepatic drug metabolism ( e.g . barbiturate , carbamazepine , rifampin , phenylhydantaoins , phenothiazine , cimetidine , Omeprazole , macrolides , imidazole , fluoroquinolines ) within 30 day prior study administration l ) Positive test result : HIV , Hepatitis B surface antigen , Hepatitis C antibody , drug abuse , pregnancy screening .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Bioequivalence Doxycycline monohydrate 100mg tablet feed condition</keyword>
</DOC>